MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Impaired lysosomal catabolism of alpha-synuclein in parkinsonian LRRK2(R1441G) mutant mouse embryonic fibroblasts

    WL. Ho, CT. Leung, HF. Liu, LF. Li, DB. Ramsden, SL. Ho (Hong Kong, Hong Kong)

    Objective: Using a unique fluorescence-based flow cytometry assay on LRRK2(R1441G) mutant mouse embryonic fibroblasts (MEFs) to elucidate whether pathogenic LRRK2 mutation affects cellular lysosomal degradation…
  • 2019 International Congress

    Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

    G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)

    Objective: To evaluate the frequency of prescription medications commonly associated with the management of PSP in the community. Background: Progressive Supranuclear Palsy (PSP) is a…
  • 2019 International Congress

    NEUROPSYCHIATRIC SYMPTOMS IN EARLY TO ADVANCED PATIENTS WITH THE RICHARDSON’S SYNDROME VARIANT OF PROGRESIVE SUPRANUCLEAR PALSY

    A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Marin-Lahoz, J. Perez-Perez, I. Aracil-Bolanos, H. Bejr-Kasem, A. Campolongo, C. Izquierdo, F. Sampedro, J. Kulisevsky (Barcelona, Spain)

    Objective: To know prevalence of neuropsychiatric symptoms in Progressive Supranuclear Palsy along disease stages. Background: Neuropsychiatric symptoms are common features in patients with Progressive Supranuclear Palsy…
  • 2019 International Congress

    Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson’s Disease and “OFF” Episodes: Post Hoc Analysis From a Phase 3 Study

    J. Hui, S. Fox, W. Neeson, P. Bhargava, E. Pappert, D. Blum, B. Navia (Los Angeles, CA, USA)

    Objective: To compare time to onset and magnitude of motor improvement following administration of apomorphine sublingual film (APL-130277; APL) vs levodopa in patients with Parkinson’s…
  • 2019 International Congress

    Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?

    M. Hussein, A. Khamis, R. Soliman, S. Ali (Beni Suef, Egypt)

    Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…
  • 2019 International Congress

    Towards unobtrusive Parkinson’s disease detection via motor symptoms severity inference from multimodal smartphone-sensor data

    D. Iakovakis, S. Hadjidimitriou, V. Charisis, K. Kyritsis, A. Papadopoulos, M. Stadtschnitzer, H. Jaeger, I. Dagklis, S. Bostantjopoulou, Z. Katsarou, L. Klingelhoefer, S. Mayer, R. Reichmann, D. Trivedi, A. Podlewska, A. Rizos, K. Chaudhuri, A. Delopoulos, L. Hadjileontiadis (Thessaloniki, Greece)

    Objective: To provide clinically-corroborated evidence of the Parkinson’s disease (PD) diagnostic potential of machine learning-based approaches for motor symptoms severity inference via multimodal data, passively…
  • 2019 International Congress

    Accuracy of preoperative microelectrode trajectory planning in patients treated with DBS – an ongoing study

    S. Ibrulj, S. Delalić, MB. Benedičič, D. Georgijev, DF. Flisar, M. Trošt (Ljubljana, Slovenia)

    Objective: To retrospectively analyze the accuracy of the preoperative Deep Brain Stimulation (DBS) trajectory planning based on final trajectories chosen with intraoperative neurophysiological testing and…
  • 2019 International Congress

    Parkinson’s disease polygenic risk score is not associated with impulse control disorders: a longitudinal study

    J. Ihle, F. Artaud, S. Bekadar, G. Magnone, H. Bertrand, S. Sambin, LL. Mariani, C. Scherzer, A. Elbaz, JC. Cornol (Paris, France)

    Objective: To examine the relationship between a polygenic risk score (GRS) associated with Parkinson’s disease (PD) and impulse control disorders (ICDs) in PD. Background: Genome…
  • 2019 International Congress

    Skin in the game: Small fiber neuropathy in Parkinson’s disease and atypical parkinsonisms.

    R. Infante, G. Rizzo, A. Incensi, C. Scaglione, S. Capellari, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: The aim of our study was to compare somatic and autonomic small fiber density, through skin biopsy, in Parkinson's disease (PD) and atypical parkinsonisms…
  • 2019 International Congress

    Impact of OFF periods on aspects of employment for people with Parkinson’s disease

    I. Iresha Abeynayake, L. Marinucci, M. Klingler, C. Kenney (Aardsley, NY, USA)

    Objective: To characterize the impact of OFF periods on aspects of employment for people with Parkinson’s disease (PD) who have OFF periods compared to those…
  • « Previous Page
  • 1
  • …
  • 1281
  • 1282
  • 1283
  • 1284
  • 1285
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley